BEI MEDICAL SYSTEMS CO INC /DE/
SC 13G, 1999-01-06
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Previous: VENATOR GROUP INC, SC 13D/A, 1999-01-06
Next: KANSAS TAX EXEMPT TRUST SERIES 29, 485BPOS, 1999-01-06



                         13G            Page 1 of 4 Pages

            SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549
                                  SCHEDULE 13G
                                 (Rule 13d-102)

  INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c),
          AND(d)AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

                        BEI Medical Systems Company, Inc.
                                (Name of Issuer)

                    Common Stock, par value $0.001 per share
                         (Title of Class of Securities)

                                   05538E1091
                                 (CUSIP number)

                                December 31, 1998
             (Date of Event Which Requires Filig of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
                                   is filed:
                                [X] Rule 13d-1(b)
                                [ ] Rule 13d-(c)
                                [ ] Rule 13d-1(d)

_________
(1) The remainder of this cover page shall be filled out for
a reporting person's initial filing on this form with
respect to the subject class of securities, and for any
subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section
18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act
(however, see the Notes).


<PAGE>
CUSIP NUMBER 05538E109   13G                 Page 2 of 4 Pages

- --------------------------------------------------------------------------
1.   NAME OF REPORTING PERSONS S.S. OR I.R.S
     IDENTIFICATION NO.OF ABOVE PERSONS

          Societe Generale Asset Management Corp. 13-3557071

- --------------------------------------------------------------------------
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a)   [ ]
(b)   [ ]

- --------------------------------------------------------------------------
3.   SEC USE ONLY


- --------------------------------------------------------------------------
4.   CITIZENSHIP OF PLACE OF ORGANIZATION

     Delaware

- ---------------------------------------------------------------------------
 
 NUMBER OF          5.   SOLE VOTING POWER
 SHARES
 BENEFICIALLY  ----------------------------------------------------------    
 OWNED BY           6.   SHARED VOTING POWER
 EACH            420,000 Shared with its investment advisory client(s)
 REPORTING     -----------------------------------------------------------
 PERSON             7. SOLE DISPOSITIVE POWER
 WITH
               -----------------------------------------------------------
                    8. SHARED DISPOSITIVE POWER
                 420,000 Shared with its investment advisory client(s)     

- ---------------------------------------------------------------------------
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
     REPORTING PERSON

     420,000 Shares

- ---------------------------------------------------------------------------
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
     EXCLUDES CERTAIN SHARES* [ ]


- ---------------------------------------------------------------------------

11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

      5.43%
- --------------------------------------------------------------------------

12.  TYPE OF REPORTING PERSON*

     IA


* SEE INSTRUCTIONS BEFORE FILLING OUT 13G

<PAGE>

                         13G            Page 3 of 4 Pages


Item 1

(a) Name of Issuer:
    BEI Medical Systems Company, Inc (the "Issuer").

(b) Address of Issuer's Principal Executive Offices: 
         100 Hollister Road, Suite 2500
         Teterbor, NJ 07608
- ----------------------------------------------------------------------------
Item 2

(a) Names of Persons Filing: Societe Generale Asset Management Corp.,
a Delaware corporation (the "Adviser")

(b) Address of Principal Business Office: The principal
business offices of the Adviser is located at
1221 Avenue of the Americas, New York, NY 10020.

(c) Citizenship: The Adviser is a Delaware corporation.

(d) Title of Class of Securities: Common Stock, par value $0.001 
                                  per share (the "Shares").

(e) CUSIP Number: 05538E1091
- -----------------------------------------------------------------------------
Item 3

If This Statement is Filed Pursuant to Rule 13d-1 (b), or 13d-2 (b) or (c), 
Check Whether the Person Filing is a:

(a)[ ] Broker or dealer registered under Section 15 of the Exchange Act.
(b)[ ] Bank as defined in Section 3(a)(6)of the Exchange Act.
(c)[ ] Insurance company as defined in Section 3(a)(19)of the Exchange Act.
(d)[ ] Investment company registered under Section 8 of the Investment Company 
       Act.
(e)[X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f)[ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1
       (b)(1)(ii)(F);
(g)[ ] A parent holding company or control person in accordance with Rule 13d-1
       (b)(1)(ii)(G);
(h)[ ] A saving association as defined in Section 3(b)of the Federal Deposit 
       Insurance Act;
(i)[ ] A church plan that is excluded from the definition of an investment 
       company under Section 3(c)(14)of the Investment Company Act;
(j)[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

If this statement is filed pursuant to Rule 13d-1(c), check this box. [ ]
- -----------------------------------------------------------------------------
Item 4

Ownership

(a) Amount Beneficially Owned: 
 
     The Adviser beneficially owns 420,000 Shares.

(b) Percentage of class: 

     The Adviser beneficially owns 5.43% of the outstanding Shares.  

(c) Number of Shares As to Which Such Persons Have: 
   (i) sole power to vote or direct the vote: None

   (ii)shared power to vote or direct the vote:  420,000

   (iii)sole power to dispose or to direct the disposition of  
       
          None

   (iv)shared power to dispose or to direct the disposition of the Adviser: 
          420,000


<PAGE>
                         13G                 Page 4 of 4 Pages

Item 5

Ownership of Five Percent or Less of a Class

Not Applicable.
- ----------------------------------------------------------------------------
Item 6

Ownership of More Than Five Percent on Behalf of Another
Person

Not Applicable.
- ----------------------------------------------------------------------------
Item 7

Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported On By the Parent
Holding Company 

Not Applicable.
- ---------------------------------------------------------------------------
Item 8

Identification and Classification of Members of the Group.

Not Applicable.
- ---------------------------------------------------------------------------
Item 9

Notice of Dissolution of Group.

Not Applicable.
- -------------------------------------------------------------------------
Item 10


Certification

By signing below, I certify that, to the best of my
knowledge and belief, the securities referred to above were
acquired in the ordinary course of business and were not
acquired for the purpose of and do not have the effect of
changing or influencing the control of the Issuer of such
securities and were not acquired in connection with or as a
participant in any transaction having such purpose or
effect.

Signature.  After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.


Dated:   January 6, 1999

SOCIETE GENERALE ASSET MANAGEMENT CORP.
By:        /s/ Jean-Marie Eveillard
Jean Marie Eveillard/President                                    
                          



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission